Atlas Trials

A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)

Clinical trial NCT07672756 · RECRUITING

Trial details

NCT number
NCT07672756
Sponsor
Chongqing Peg-Bio Biopharm Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Phenylketonuria (PKU)
Start date
2025-07-20
Primary completion
2027-06-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.